Delivery Order SPE2DB20D2104-SPE2DB24FU21K
Award Date
5/15/24
Potential Completion Date
5/16/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,128.16 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,444.41 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. The contract has an ultimate completion date of November 28, 2022 and was awarded on November 25, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.90 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. The $1,445.62 firm fixed price contract has a completion date of November 21, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to AmerisourceBergen Drug Corp, has a ceiling value of $1,344.99 and an ultimate completion date of August 22, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. This award is likely part of a larger Indefinite...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension (180 ml) to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $4,747.53, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,688.86 and a period of performance ending on January 22, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,609.81 firm fixed-price delivery order is for the drug Quillivant XR 25 mg/5 ml suspension, with a period of performance through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.74 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) and has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 120 ml, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,619.38 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...